We think that the evidence is sufficient for us to be able to prove it or we would not have filed the case, and we intend to file many more in the coming days and weeks," Pennock said during the Zoom conference, noting the first case filed involves a 44-year-old woman from Louisiana who has taken both drugs, Ozempic first and then Mounjaro, at the discretion of her doctor
Furthermore, it improves blood circulation, promotes antioxidants, and improves collagen production
Ro's role as a day-one launch channel for oral GLP-1 options from both Novo Nordisk and Eli Lilly further expands the addressable patient population to those who cannot or will not self-inject, meaningfully widening the top of the obesity funnel
Pharma companies may transfer known processes to a CDMO (tech transfer
Weekly Coaching Receive personalized education, training, and guidance throughout your compounded treatment